Literature DB >> 1775836

Infections due to Stomatococcus mucilaginosus: 10 cases and review.

D P Ascher1, C Zbick, C White, G W Fischer.   

Abstract

We describe 10 new cases of bacteremia due to Stomatococcus mucilaginosus and review eight other cases that have been described in the literature. The most common clinical presentations were endocarditis, catheter-related infection, and septicemia. Commonly associated risk factors were intravenous drug abuse, cardiac valve disease, the presence of foreign bodies (especially indwelling vascular catheters), and immunocompromised states. S. mucilaginosus bacteremia is readily treatable with antibiotics. This organism is of low virulence, but appears to be an emerging pathogen. Infection due to S. mucilaginosus is likely to be underreported because the organism may be easily misidentified and information on it is not included in the databases of many automated microbiologic identification systems.

Entities:  

Mesh:

Year:  1991        PMID: 1775836     DOI: 10.1093/clinids/13.6.1048

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  10 in total

1.  Rothia bacteremia: a 10-year experience at Mayo Clinic, Rochester, Minnesota.

Authors:  Poornima Ramanan; Jason N Barreto; Douglas R Osmon; Pritish K Tosh
Journal:  J Clin Microbiol       Date:  2014-06-20       Impact factor: 5.948

2.  Vertebral osteomyelitis with Stomatococcus mucilaginosus.

Authors:  H Nielsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-09       Impact factor: 3.267

3.  Association of Stomatococcus mucilaginosus with cholangitis.

Authors:  V P Harjola; M Valtonen; A Sivonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

4.  Study of Stomatococcus mucilaginosus isolated in a hospital ward using phenotypic characterization.

Authors:  F H van Tiel; B F Slangen; H C Schouten; J A Jacobs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

Review 5.  Bacteremia caused by Stomatococcus mucilaginosus: report of seven cases and review of the literature.

Authors:  A Kaufhold; R R Reinert; W Kern
Journal:  Infection       Date:  1992 Jul-Aug       Impact factor: 3.553

6.  Antimicrobial susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp.

Authors:  C von Eiff; M Herrmann; G Peters
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

7.  Stomatococcus mucilaginosus septicemia in a patient with acute lymphoblastic leukaemia.

Authors:  M Treviño; A García-Zabarte; A Quintás; E Varela; J M López-Paz; A Jato; C García-Riestra; B J Regueiro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-07       Impact factor: 3.267

8.  A case of peritoneal dialysis-associated peritonitis by Rothia mucilaginosa.

Authors:  Byeong Gwan Kim; A Young Cho; Sang Sun Kim; Seong Hee Lee; Hong Shik Shin; Hyun Ju Yoon; Jeong Gwan Kim; In O Sun; Kwang Young Lee
Journal:  Kidney Res Clin Pract       Date:  2015-07-29

9.  Rothia mucilaginosa bacteremia, meningitis leading to diffuse cerebritis in an adolescent patient undergoing acute myeloid leukemia chemotherapy causing significant morbidity.

Authors:  Rachel Dena Robertson; Arun Panigrahi; Ritu Cheema
Journal:  SAGE Open Med Case Rep       Date:  2021-12-08

10.  Rothia mucilaginosa pneumonia diagnosed by quantitative cultures and intracellular organisms of bronchoalveolar lavage in a lymphoma patient.

Authors:  Eun-Jung Cho; Heungsup Sung; Sook-Ja Park; Mi-Na Kim; Sang-Oh Lee
Journal:  Ann Lab Med       Date:  2013-02-21       Impact factor: 3.464

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.